166 related articles for article (PubMed ID: 17077303)
1. Human ACE and bradykinin B2 receptors form a complex at the plasma membrane.
Chen Z; Deddish PA; Minshall RD; Becker RP; Erdös EG; Tan F
FASEB J; 2006 Nov; 20(13):2261-70. PubMed ID: 17077303
[TBL] [Abstract][Full Text] [Related]
2. Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors.
Chen Z; Tan F; Erdös EG; Deddish PA
Hypertension; 2005 Dec; 46(6):1368-73. PubMed ID: 16246972
[TBL] [Abstract][Full Text] [Related]
3. Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors.
Marcic B; Deddish PA; Skidgel RA; Erdös EG; Minshall RD; Tan F
J Biol Chem; 2000 May; 275(21):16110-8. PubMed ID: 10748135
[TBL] [Abstract][Full Text] [Related]
4. ACE activity is modulated by kinin B2 receptor.
Sabatini RA; Guimarães PB; Fernandes L; Reis FC; Bersanetti PA; Mori MA; Navarro A; Hilzendeger AM; Santos EL; Andrade MC; Chagas JR; Pesquero JL; Casarini DE; Bader M; Carmona AK; Pesquero JB
Hypertension; 2008 Mar; 51(3):689-95. PubMed ID: 18212275
[TBL] [Abstract][Full Text] [Related]
5. [ACE inhibitors--activators of kinin receptors].
Kugaevskaia EV; Eliseeva IuE
Biomed Khim; 2011; 57(3):282-99. PubMed ID: 21863742
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells.
Minshall RD; Tan F; Nakamura F; Rabito SF; Becker RP; Marcic B; Erdös EG
Circ Res; 1997 Nov; 81(5):848-56. PubMed ID: 9351459
[TBL] [Abstract][Full Text] [Related]
7. Prolonged signalling and trafficking of the bradykinin B2 receptor stimulated with the amphibian peptide maximakinin: insight into the endosomal inactivation of kinins.
Bawolak MT; Roy C; Gera L; Marceau F
Pharmacol Res; 2012 Feb; 65(2):247-53. PubMed ID: 22108573
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of bradykinin and resensitization of its B2 receptor.
Marcic B; Deddish PA; Jackman HL; Erdös EG
Hypertension; 1999 Mar; 33(3):835-43. PubMed ID: 10082496
[TBL] [Abstract][Full Text] [Related]
9. Kallikrein activates bradykinin B2 receptors in absence of kininogen.
Biyashev D; Tan F; Chen Z; Zhang K; Deddish PA; Erdös EG; Hecquet C
Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H1244-50. PubMed ID: 16272198
[TBL] [Abstract][Full Text] [Related]
10. Kinins, receptors, kininases and inhibitors--where did they lead us?
Erdös EG; Marcic BM
Biol Chem; 2001 Jan; 382(1):43-7. PubMed ID: 11258670
[TBL] [Abstract][Full Text] [Related]
11. A cleavable signal peptide enhances cell surface delivery and heterodimerization of Cerulean-tagged angiotensin II AT1 and bradykinin B2 receptor.
Quitterer U; Pohl A; Langer A; Koller S; Abdalla S
Biochem Biophys Res Commun; 2011 Jun; 409(3):544-9. PubMed ID: 21600887
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence resonance energy transfer of GFP and YFP by spectral imaging and quantitative acceptor photobleaching.
Dinant C; van Royen ME; Vermeulen W; Houtsmuller AB
J Microsc; 2008 Jul; 231(Pt 1):97-104. PubMed ID: 18638193
[TBL] [Abstract][Full Text] [Related]
13. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.
Deddish PA; Marcic B; Jackman HL; Wang HZ; Skidgel RA; Erdös EG
Hypertension; 1998 Apr; 31(4):912-7. PubMed ID: 9535414
[TBL] [Abstract][Full Text] [Related]
14. Design of fluorescent bradykinin analogs: application to imaging of B2 receptor-mediated agonist endocytosis and trafficking and angiotensin-converting enzyme.
Gera L; Bawolak MT; Roy C; Lodge R; Marceau F
J Pharmacol Exp Ther; 2011 Apr; 337(1):33-41. PubMed ID: 21205920
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C and phosphatase inhibitors block the ability of angiotensin I-converting enzyme inhibitors to resensitize the receptor to bradykinin without altering the primary effects of bradykinin.
Marcic BM; Erdös EG
J Pharmacol Exp Ther; 2000 Aug; 294(2):605-12. PubMed ID: 10900238
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin B(2) receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates.
Bachvarov DR; Houle S; Bachvarova M; Bouthillier J; Adam A; Marceau F
J Pharmacol Exp Ther; 2001 Apr; 297(1):19-26. PubMed ID: 11259523
[TBL] [Abstract][Full Text] [Related]
17. Effects of the N-terminal sequence of ACE on the properties of its C-domain.
Marcic B; Deddish PA; Jackman HL; Erdös EG; Tan F
Hypertension; 2000 Jul; 36(1):116-21. PubMed ID: 10904022
[TBL] [Abstract][Full Text] [Related]
18. Tissue kallikrein actions at the rabbit natural or recombinant kinin B2 receptors.
Houle S; Molinaro G; Adam A; Marceau F
Hypertension; 2003 Mar; 41(3):611-7. PubMed ID: 12623967
[TBL] [Abstract][Full Text] [Related]
19. Kallikreins when activating bradykinin B2 receptor induce its redistribution on plasma membrane.
Hecquet C; Becker RP; Tan F; Erdös EG
Int Immunopharmacol; 2002 Dec; 2(13-14):1795-806. PubMed ID: 12489794
[TBL] [Abstract][Full Text] [Related]
20. Close association of B2 bradykinin receptors with P2Y2 ATP receptors.
Yashima S; Shimazaki A; Mitoma J; Nakagawa T; Abe M; Yamada H; Higashi H
J Biochem; 2015 Aug; 158(2):155-63. PubMed ID: 25713410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
